About James La Rossa

This author has not yet filled in any details.
So far James La Rossa has created 141 blog entries.

Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom

By |2021-01-19T12:45:20-08:00January 19th, 2021|Brief Bulletins from the Field, We Know Psychiatry|

SUMMARY In this study, we observed that compared to women with no prior cancer, breast cancer survivors had higher risk of anxiety, depression, sleep problems, sexual dysfunction, fatigue, receipt of opioid analgesics, and pain. Relative risks estimates tended to decrease over time, but anxiety and depression were significantly increased for [...]

IN PRESS, V51, N2, 2021

By |2021-01-05T10:43:53-08:00January 5th, 2021|Articles in Press, Brief Bulletins from the Field|

 ORIGINAL RESEARCH Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder By Charles L. Bowden, Richard Priesmeyer, Mauricio Tohen, Vivek Singh, Joseph R. Calabrese, Terry Ketter, Andrew Nierenberg, Michael E. Thase, Gregg Siegel, Leslie H. Siegel, Jim Mintz, Rif S. El-Mallakh, Susan L. McElroy, Melissa Martinez [...]

IN PRESS: 2021 Black Book of Psychotropic Dosing and Monitoring, By Charles DeBattista, Alan F. Schatzberg

By |2020-12-02T08:26:16-08:00December 2nd, 2020|Articles in Press, Brief Bulletins from the Field, We Know Psychiatry|

IntroductIon Psychotropics continue to be among the most commonly prescribed medications in clinical practice. There are over 380 million outpatient psychotropic prescriptions in the US every year Greenblatt et al. (2018). The majority of these prescriptions are for antidepressants (58%) followed by anxiolytics (22%), hypnotics (14%) and antipsychotics (5%). Since [...]

Suicide Prevention in the COVID-19 Era Transforming Threat Into Opportunity

By |2020-10-20T09:07:02-07:00October 20th, 2020|Brief Bulletins from the Field, We Know Psychiatry|

From: JAMA Psychiatry. Published online October 16, 2020. doi:10.1001/jamapsychiatry.2020.3746 By Christine Moutier, MD Introduction International and US experts on suicide have expressed concerns about the potential the coronavirus disease 2019 (COVID-19) pandemic has to increase the risk of suicide through its effects on a number of well-established suicide risk factors.1,2 Suicide surveillance [...]